Skip to content

Investigating the impact of fat injection on female stress urinary incontinence treatment.

Autologous Periurethral Fat Injection for Treating Female Stress Urinary Incontinence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160521027998N11
Enrollment
104
Registered
2025-01-26
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress incontinence. Stress incontinence (female) (male)

Interventions

Intervention 1: Intervention group: In the treatment group, patients will undergo fat injection after Kelley pillication. In the first stage, autologous fat will be harvested from the patients. For th

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having at least one vaginal birth Diagnosis of stress urinary incontinence based on clinical history, positive cough test, or urodynamic studies Not receiving concomitant medication, physical therapy, weight loss, or hormone therapy

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study History of urinary tract disorders in the patient, which was extracted from the clinical history or previous clinical records (if available). Urinary incontinence related to other underlying causes, including neurological disorders

Design outcomes

Primary

MeasureTime frame
Urinary incontinence. Timepoint: At the beginning of the study and 3 months after fat injection. Method of measurement: ICIQ-SF questionnaire, Cough stress test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hajihashemi

Esfahan University of Medical Sciences

m_hajihashemy@med.mui.ac.ir+98 31 3776 6578

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026